コンテンツへスキップ
Merck
  • Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: case report and literature review.

Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: case report and literature review.

The Kaohsiung journal of medical sciences (2011-04-06)
Yueh-Hung Chou, Hsin-Yi Wang, Min-Shu Hsieh
要旨

Kayexalate (sodium polystyrene sulfonate) is a cation-exchange resin used to treat patients with hyperkalemia. Concomitant administration of kayexalate and sorbitol may induce gastrointestinal injury, which is potentially lethal. However, this well-documented complication is often underrecognized both clinically and pathologically. We propose a typical case along with colonoscopic photos and microscopic pictures. Additionally, we also present a review of the literature on this rare drug-induced side effect.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
D-ソルビトール, ≥98% (GC)
Sigma-Aldrich
D-ソルビトール, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D-ソルビトール, 99% (GC)
Sigma-Aldrich
D-ソルビトール, ≥98% (GC), for molecular biology
USP
ソルビトール, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-ソルビトール, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
ソルビトール F 溶液, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
D-ソルビトール, FCC, FG
Supelco
ソルビトール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-ソルビトール, ≥98% (GC), BioXtra
ソルビトール, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
D-ソルビトール, liquid, tested according to Ph. Eur.